Anna Buisan Farré2024-11-19T10:45:41+01:00

Anna Buisan Farré

Member of Research Line in Mechanisms for tissue repair and regeneration research line

ORCID: 0000-0002-1821-0503

Anna Buisan Farré has a bachelor’s degree in Biochemistry from the Autonomous University of Barcelona (UAB) and a master’s degree in Molecular Biotechnology from the University of Barcelona (UB). She started her career as a R&D laboratory technician in a biotechnology company focused on tuberculous vaccines. At present Anna is pursuing a phD at TR2Lab.

My last happenings:

  • Closing Event of the EHECADI Project A Digital and Collaborative Model to Address Health and Social Challenges

Closing Event of the EHECADI Project: A Digital and Collaborative Model to Address Health and Social Challenges

On Friday, February 21, the closing event of the EUROPEAN HEALTH CARE FINAL DISSERTATION: a digital, international, and collaborative co-designed model to address health care societal challenges (EHECADI project) took place. The project is coordinated by the University of Vic - Central University of Catalonia (UVic-UCC) and is an Erasmus+ European initiative led by Principal Investigator (PI) Ester Goutan Roura. It has developed a digital, international, collaborative, and co-created model to address social and health challenges through an international online platform. This initiative supports students from various health disciplines (nursing, physiotherapy, occupational therapy, and [...]

February 27, 2025|
  • Albert Espona Noguera

Albert Espona Noguera, new member at TR2Lab

The scientific community of TR2Lab welcomes Dr. Albert Espona Noguera, who joins as a coordinator in Biomaterials for Advancing Therapeutics and Regenerative Medicine research line. We are excited to have his talent and dedication in our community!

February 26, 2025|
  • martaamaro

Marta Amaro Castillo, new member at TR2Lab

The scientific community of TR2Lab welcomes Marta Amaro Castillo, who joins as a student linked to group Mechanisms of tissue repair and regeneration research line. We are excited to have her talent and devotion in our community!

February 21, 2025|
Go to Top